Eden Research Plc, the AIM-listed natural micro-encapsulation company, announced it has signed an exclusive option agreement with Taminco BVBA’ s crop protection division following a series of successful field trials conducted during the second half of 2014. Taminco BVBA (“Taminco”) is a subsidiary of Eastman Chemical Company.

The Agreement grants Taminco the right to further evaluate and conduct large-scale marketing and regulatory trials with Eden’s nematicide product B2Y for crop protection until March 31, 2016. It is anticipated that following a successful outcome in 2015, Eden and Taminco will negotiate a global licensing arrangement to allow the commercialisation of this product. The nematicide B2Y uses Eden’s naturally-derived active ingredients and GO-E Inside, Eden’s natural micro-encapsulation technology.

“Since August 2014, Taminco has been evaluating Eden’s nematicide product, B2Y, and has seen very good results,”  Sean Smith, Chief Executive Officer of Eden, said, “As such, Taminco has decided to further evaluate the product and expand the trial work to a much larger scale with a view to registering and ultimately selling the product on a global basis.”